SCHEMBL19081512

SCHEMBL19081512

c1ccc(-c2c3ccccc3c(-c3cccc(-c4ccc5oc6ccc7c8cc9ccccc9cc8oc7c6c5c4)c3)c3ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.38
PLA2G4A P47712 4/20 0.38
PLA2G10 O15496 1/20 0.38
ESR1 P03372 5/20 0.36
ESR2 Q92731 5/20 0.36
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
CYP3A4 P08684 1/20 0.34
ALPI P09923 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
PKM P14618 1/20 0.34
HPGD P15428 1/20 0.34
CASP3 P42574 1/20 0.34
RECQL P46063 1/20 0.34
BLM P54132 1/20 0.34
CASP7 P55210 1/20 0.34
CASP6 P55212 1/20 0.34
KMT2A Q03164 1/20 0.34
MCL1 Q07820 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081509 0.93 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL19076314 0.91 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL21450750 0.90 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL16067690 0.90 PLA2G2A (0.45) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL17932134 0.89 PLA2G2A (0.45) PLA2G2APLA2G4APLA2G10KDM4EMEN1
SCHEMBL17932135 0.89 PLA2G2A (0.45) PLA2G2APLA2G4APLA2G10KDM4EMEN1
SCHEMBL16067687 0.89 PLA2G2A (0.44) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL16068035 0.89 PLA2G2A (0.44) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL19081422 0.89 ESR1 (0.42) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL16068003 0.89 PLA2G2A (0.44) PLA2G2APLA2G4APLA2G10ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 PLA2G2A 4330/4885PLA2G4A 4338/4885PLA2G10 4054/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 PLA2G2A 4330/4885PLA2G4A 4338/4885PLA2G10 4054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.